Cardiff Oncology, Inc. (CRDF) has seen some recent action in the stock market and its stock were last quoted at $5.69 yesterday. Traders are starting to take interest of CRDF as the stock traded as high as $6.03 and as low as $5.30 in the last market day.

Cardiff Oncology, Inc. (CRDF) average trading volume is 778.64K. However, in the last market day Cardiff Oncology, Inc. (CRDF) exchanged 712,776 shares. The 1st support level on CRDF is $5.54. CRDF fifty day moving average is $4.63 and CRDF two hundred day moving average is $3.22.

Cardiff Oncology, Inc. (CRDF) most recent performance has been specified by the recent movement in CRDF stock. CRDF has performed 19.04% over the past 30 days, CRDF has performed 378.15% over the past 3 months and CRDF has shown 234.71% over the past 12 months. Cardiff Oncology, Inc. (CRDF) has a 12 month range of $0.83 to $6.85. Cardiff Oncology, Inc. (CRDF) is trading 711.70% from its 12 month low and -16.92% from its 12 month high. Cardiff Oncology, Inc. (CRDF) is showing a 10.25% short float showing the sum short in the float.

CRDF has 9.91M shares outstanding and 9.73M shares in the float. Cardiff Oncology, Inc. (CRDF) currently has a market cap of $108.96M and income of -16.60M. The EPS next quarter for CRDF is -0.24 and forecasted EPS next year is 0.90%. The market cap of Cardiff Oncology, Inc. (CRDF) at $108.96M signifies how many Traders own shares of CRDF and is based off the last price ($5.69) of CRDF and the sum of shares outstanding (9.91M) with Cardiff Oncology, Inc. (CRDF).

Cardiff Oncology, Inc. (CRDF) has total cash (mrq) of 9.28M, total cash per share (mrq) of 0.75, total debt of CRDF stands at 1.52M and total debt/equity (mrq) is 24.75. . Cardiff Oncology, Inc. (CRDF) running cash flow (ttm) is -13.28M, CRDF leveraged free cash flow (ttm) is -7.72M.

CRDF is trading 18.38% above (bullish) its SMA20, 41.28% above (bullish) its SMA50 and 177.28% above (bullish) its SMA200.